Top of the morning to you and a pleasure to see you again. The skies are cloudy, but our spirits are sunny. Why? Two reasons. So far, we have not experienced any tech glitches today and, as the Morning Mayor taught us: Every brand new day should be unwrapped like a precious gift. We take this seriously, as you probably know. This calls, of course, for our usual celebration - a cup of stimulation. Southern Pecan is our delicious choice. Meanwhile, we have another list of tidbits for you. So dig in and have a great day. And let us know if you hear of anything saucy...
Glaxo Rejects The Idea Of Buying AstraZeneca (Reuters)
Novartis Pays $1.5B For Fougera Generic Skin Drugmaker (Bloomberg News)
NIH And Three Drugmakers For Discovery (Reuters)
29 More Drugs Face FDA Approval In 2012 (The Street)
Germany Rejects New Glaxo Lupus Drug (Reuters)
J&J And Bayer Seek Added Use For Xarelto (Associated Press)
Chelsea May Seek Limited Use For Northera Blood Pressure Med (Med City News)
Studies Reveals How Vioxx Raised Heart Risk (Wall Street Journal)
Merck To Expand North Carolina Packaging Center (Raleigh News & Observer)
Australia Cuts Prices On More Medicines (Pharma Times)
Abbott And Biocon To Develop Nutrition Products For India (Reuters)
Cipla Lowers Price Of Generic Nexavar (Economic Times)
EDITOR'S NOTE: Please check this post for updates